Abstract
To observe the protective effect of orally administrated Rexflavone (Sophorae fructus extract) for the postmenopausal symptoms, a randomized double-blind placebo controlled clinical trial was designed. Rexflavone significantly improved 11 menopausal symptoms including hot flash, which was evaluated by the modified Kupperman Index (KI), while hormone level and lipid profile were little changed by consumption. Rexflavone group significantly decreased KI score (−14.91 ± 8.79) compared to placebo group (−11.45 ± 6.62) as a representative index for improvement of menopausal symptoms (p < 0.05). We found that Rexflavone has no adverse effect to be safe for long term consumption. It was shown that the consumption of Rexflavone possessed beneficial effects on the postmenopausal symptoms in postmenopausal women.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Booth, N. L., Overk, C. R., Yao, Ping, Totura, S., Deng, Y., Hedayat, A. S., Bolton, J. L., Pauli, G. F., and Farnsworth, N. R., Seasonal Variation of Red Clover (Trifolium pratense L., Fabaceae) Isoflavones and Estrogenic Activity. J. Agric. Food Chem., 54, 1277–1282 (2006).
Cassady, J. M., Zennie, T. M., Chae, Y. H., Ferin, M. A., Portuondo, N. E., and Baird, W. M., Use of a mammalian cell culture benzo[a]pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L. Cancer Res., 48, 6257–6261 (1988).
Chen, Y. M., Ho, S. C., Lam, S. S. H., Ho, S. S. S., and Woo, J. L. F., Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J. Clin. Endocrinol. Metab., 88, 4740–4747 (2003)
Choi, S. E., Shim, J. G., Oh, M. H., Kwon, S. H., and Lee, M. W., Anti-hyperlipidemic effect of sophorae fructus on hyperlipidemic rat induced by high fat-rich diet. Kor. J. Pharmacogn., 40, 244–250 (2009).
Freedman, R. R. and Dinsay, R., Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertil. Steril., 74, 20–23 (2000).
Freedman, R. R., Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil. Steril., 70, 332–337 (1998).
Glazier, M. G. and Bowman, M. A., A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch. Int. Med., 161, 1161–1172 (2001).
Hensley, K., Mou, S., Pye, Q. N., Dixon, R. A., Summner, L. W., and Floyd, R. A., Chemical versus pharmacological actions of nutraceutical phytochemicals: antioxidant and anti inflammatory modalities. Curr. Top. Nutraceutical Res., 2, 13–25 (2004).
Ho, L., Xu, Y., Xue, H., Wang, W., Zhou, Z., Chen, P., and Fan, M., Studies on the antifertility constituents of Huai Jiao. I. Isolation of constituents I-XI and identification of I-IV and IX. Shengzhi Yu Biyun, 2, 23–27 (1982).
Hou, L., Compositions with analgesic, antipyretic and antiinflammatory properties/Compositions with analgesic, antipyretic and antiinflammatory properties comprising talc, silkworm excrement and various herbs. US patent application 5908628A (1999).
Hussain, M., Banerjee, M., Sarkar, F. H., Djuric, Z., Pollak, M. N., Doerge, D., Fontana, J., Chinni, S., Davis, J., Forman, J., Wood, D. P., and Kucuk, O., Soy isoflavones in the treatment of prostate cancer. Nutr. Cancer, 47, 111–117 (2003).
Joo, S. S., Kang, H. C., Lee, M. W., Choi, Y. W., and Lee, D. I., Inhibition of IL-1 and IL-6 in osteoblast-like cell by isoflavones extracted from Sophorae fructus. Arch. Pharm. Res., 26, 1029–1035 (2003).
Joo, S. S., Won, T. J., Kang, H. C., and Lee, D. I., Isoflavones extracted from Sophorae fructus upregulate IGF-I and TGF- and inhibit osteoclastogenesis in rat born marrow cells. Arch. Pharm. Res., 27, 99–105 (2004).
Jung, S. H., Cho, S. H., The, H. D., Lee, J. H., Ju, J. H., Kim, M. K., Lee, S. H., Ryu, J. C., and Kim, Y. S., Structural requirement of isoflavonones for the inhibitory activity of interleukin-5. Eur. J. Med. Chem., 38, 537–545 (2003).
Kassi, E., Papoutsi, Z., Fokialakis, N., Messari, I., Mitakou, S., and Moutsatsou, P., Greek plant extracts exhibit selective estrogen receptor modulator (SERM)-like properties. J. Agric. Food Chem., 52, 6956–6961 (2004).
Kim, H. J., Kim, M. K., Shim, J. G., Yeom, S. H., Kwon, S. H., and Lee, M. W., Anti-oxidative phenolic compounds from Sophorae fructus. Nat. Prod. Sci., 10, 330–334 (2004).
Kite, G. C., Veitch, N. C., Boalch, M. E., Lewis, G. P., Leon, C. J., and Simmonds, M. S. J., Flavonol tetraglycosides from fruits of Styphnolobium japonicum (Leguminosae) and the authentication of Fructus Sophorae and Flos Sophorae. Phytochemistry (Elsevier), 70, 785–794 (2009).
Kupperman, H. S., Blatt, M. H. G., Wiesbader, H., and Filler, W., Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indexes. J. Clin. Endocrinol. Metab., 13, 688–703 (1953).
Kupperman, H. S., Wetchler, B. B., and Blatt, M. H. G., Contemporary therapy of the menopausal symptom. J. Am. Med. Assoc., 171, 1627–1637 (1959).
Li, Y., Antipyretic health beverage from traditional Chinese medicine for preventing and treating heart diseases and viral influenza. Faming Zhuanli Shenqing Gongkai Shuomingshu, pp. 6, (2007).
Liu, J., Sun, Y., and Yue, H., A Chinese medicinal lotion for external use for treating reproductive system diseases of women containing lightyellow sophora root. Faming Zhuanli Shenqing Gongkai Shuomingshu. CN patent application 1403117A (2003).
McCormick, D. L., Johnson, W. D., Bosland, M. C., Lubet, R. A., and Steele, V. E., Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by bowman-birk inhibitor. Nutr. Cancer, 57, 184–193 (2007).
Morel, C., Stermitz, F. R., Tegos, G., and Lewis, K., Isoflavones as potentiators of antibacterial activity. J. Agric. Food Chem., 51, 5677–5679 (2003).
Mu, L., Liao, H. W., Yin, Y., and Zheng, M., A method for screening common Chinese herb medicine as bacterial inhibitor. Zhongguo Shipin Tianjiaji., 122, 112–117 (2008).
Narayanan, M. C., Rao, P. R., Shanmugam, N. N., Gopalakrishnan, Sethuraman, M., and Devi, K., Isolation and characterisation of bioactive isoflavonoids from the roots of Dalbergia horrida. Nat. Prod. Res. Part A: Struc. and Synth., 21, 903–909 (2007).
Parmar, V. S., Bisht, K. S., Jain, R., Singh, S., Sharma, S. K., Gupta, S., Malhotra, S., Tyagi, O. D., Vardhan, A., Pati, H. N., Berghe, D. V., Vlietinck, A. J., Synthesis, antimicrobial and antiviral activities of novel polyphenolic compounds. Indian. J. Chem., Section B: Org. Chem. Including Med. Chem., 35B, 220–232 (1996).
Patisaul, H. B., Dindo, M., Whitten, P. L., and Young, L. J., Soy isoflavone supplements antagonize reproductive behavior and estrogen receptor alpha- and beta-dependent gene expression in the brain. Endocrinology, 142, 2946–2952 (2001).
Pinegrin, B. V., Dimitrov, T., Lvov, V. L., Slesarev, V. I., and Khaitov, M. R., Dietary and pharmaceutical compositions using a peptidoglycan for treatment of anemia, thrombocytopenia, and leukopenia. U.S. Patent Appl. Publ., pp. 13, (2004).
Shim, J. G., Yeom, S. H., Kim, H. J., Choi, Y. W., Lee, D. I, Song, K. Y., Kwon, S. H., and Lee, M. W., Bone loss preventing effect of Sophorae Fructus on ovariectomized rats. Arch. Pharm. Res., 28, 106–110 (2005).
Tanaka, H., Sato, M., Oh-Uchi, T., Yamaguchi, R., Etoh, H., Shimizu, H., Sako, M., and Takeuchi, H., Antibacterial properties of a new isoflavonoid from Erythrina poeppigiana against methicillin-resistant Staphylococcus aureus. Phytomed., 11, 331–337 (2004).
Thijs, I., Neven, P., Van Hooff, I., Tonglet, R., Van Belle, Y., De Muylder, X., and Vanderick, G., Estrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium. Eur. J. Cancer, 36, S108–S109 (2000).
Tice, J. A., Ettinger, B., Ensrud, K., Wallace, R., Blackwell, T., and Cummings, S. R., Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. A randomized controlled trial. J. Am. Med. Assoc., 290, 207–214 (2003).
Webb, C. M., Hayward, C. S., Mason, M., Ilsley, C. D., and Collins, P., Coronary vasomotor and blood flow responses to isoflavone-intact soya protein in subjects with coronary heart disease or risk factors for coronary heart disease. Clin. Sci., 115, 353–359 (2008).
Yankep, E., Njamen, D., Fotsing, M. T., Fomum, Z. T., Mbanya, J. C., Giner, R. M., Recio, M. C., Manez, S., and Rios, J. L., Griffonianone D, an Isoflavone with Antiinflammatory Activity from the Root Bark of Millettia griffoniana. J. Nat. Prod., 66, 1288–1290 (2003).
Zeng, X., Feng, Y., Yang, L., Huang, Y., Zhou, D., Sun, J., Liu, Y., and Deng, Y., Single- and multiple-dose pharmacokinetics of genistein capsules in healthy Chinese subjects: a phase I, randomized, open-label study. Curr. Ther. Res., 69, 318–333 (2008).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Lee, J., Kim, K.W., Kim, HK. et al. The effect of rexflavone (Sophorae Fructus Extract) on menopausal symptoms in postmenopausal women: A randomized double-blind placebo controlled clinical trial. Arch. Pharm. Res. 33, 523–530 (2010). https://doi.org/10.1007/s12272-010-0405-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0405-0